Compliance with timolol treatment in glaucoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-03

AUTHORS

Alan P Rotchford, K M Murphy

ABSTRACT

PURPOSE: To assess levels of compliance in elderly patients on timolol eyedrops for glaucoma. METHODS: A postal questionnaire was sent from the general practitioner to 86 patients over 55 years of age on repeat prescriptions for timolol eyedrops. The questionnaire asked details about the duration of treatment, family history, the level of understanding of the disease and the importance of treatment, other regular medication, side-effects attributed to the drops and how often patients omitted their drops. A search of practice and local hospital dispensing data was carried out to assess how frequently monthly repeat prescriptions for timolol eyedrops were dispensed over a 12 month period. This allowed a total volume to be calculated for each patient. RESULTS: Twenty-four per cent of patients admitted to omitting eyedrops either occasionally or frequently. Fifty-one per cent were found to have had insufficient drops dispensed to comply with treatment as prescribed. In non-complaint patients the mean period without drops was 85 days of the year, with a maximum of 165 days. CONCLUSION: Compliance with treatment is poor and patients underestimate their level of defaulting when questioned. More... »

PAGES

eye199856

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/eye.1998.56

DOI

http://dx.doi.org/10.1038/eye.1998.56

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024045351

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9683946


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "England", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Family Practice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glaucoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ophthalmic Solutions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Compliance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Timolol", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "The Surgery, School Lane, Alconbury, Huntingdon, Cambs PE17 5EQ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rotchford", 
        "givenName": "Alan P", 
        "id": "sg:person.01171364314.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171364314.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hlabisa Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414191.8", 
          "name": [
            "Hlabisa Hospital, Private Bag X5001 Hlabisa KwaZulu-Natal, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murphy", 
        "givenName": "K M", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00005650-196901000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000806404"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005650-196901000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000806404"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9394(86)90939-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001072527"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(75)92192-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006965428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)74225-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025525373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.2.6197.1031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029679341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197308022890506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034091065"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.1.5638.218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034406825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0037-7856(74)90039-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040356753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-8703(95)90368-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040409546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.66.7.464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044173821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0271-5384(81)90063-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044427350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0271-5384(81)90063-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044427350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.61.8.531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046737054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1755-3768.1992.tb04128.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051224189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1755-3768.1992.tb04128.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051224189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.67.1.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052616245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2105/ajph.83.5.711", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068874631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080506739", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082450123", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-03", 
    "datePublishedReg": "1998-03-01", 
    "description": "PURPOSE: To assess levels of compliance in elderly patients on timolol eyedrops for glaucoma.\nMETHODS: A postal questionnaire was sent from the general practitioner to 86 patients over 55 years of age on repeat prescriptions for timolol eyedrops. The questionnaire asked details about the duration of treatment, family history, the level of understanding of the disease and the importance of treatment, other regular medication, side-effects attributed to the drops and how often patients omitted their drops. A search of practice and local hospital dispensing data was carried out to assess how frequently monthly repeat prescriptions for timolol eyedrops were dispensed over a 12 month period. This allowed a total volume to be calculated for each patient.\nRESULTS: Twenty-four per cent of patients admitted to omitting eyedrops either occasionally or frequently. Fifty-one per cent were found to have had insufficient drops dispensed to comply with treatment as prescribed. In non-complaint patients the mean period without drops was 85 days of the year, with a maximum of 165 days.\nCONCLUSION: Compliance with treatment is poor and patients underestimate their level of defaulting when questioned.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/eye.1998.56", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097007", 
        "issn": [
          "0950-222X", 
          "1476-5454"
        ], 
        "name": "Eye", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Compliance with timolol treatment in glaucoma", 
    "pagination": "eye199856", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "728e7a1bcea73101eec0601d42258dfdbe9c7732bc720474603e5c9d689335a2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9683946"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8703986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/eye.1998.56"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024045351"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/eye.1998.56", 
      "https://app.dimensions.ai/details/publication/pub.1024045351"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29216_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/eye199856"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/eye.1998.56'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/eye.1998.56'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/eye.1998.56'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/eye.1998.56'


 

This table displays all metadata directly associated to this object as RDF triples.

178 TRIPLES      21 PREDICATES      59 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/eye.1998.56 schema:about N31c79057b7f0463f9863dd245080d50b
2 N39d59dce1b0a4ea5b749ccd5335a2ee0
3 N4ad39dae58e646828506bd199487195e
4 N5077a23d800b4ba087ae31c61be07868
5 N6a13041ac19947c08acf35ec4afc5272
6 N7c053ab6565e46e98d965aff67df398e
7 N7c8dedd3ef3f43c6bad2fafda1a3e738
8 Na67d9845956343f3b8499d77c853b6ca
9 Nab873c953879472e92d36e41615a83ee
10 Ncec0bedaf7334dc2b608b95e9d6038b7
11 Nd2f8e82593e44154ae9397c62f4517d5
12 Nd9a2397c4784435f816fba057952861f
13 Ne5ea788cb1114275bdbc580b9f437f0b
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N8870332cc4e64383ade480c42fe5317a
17 schema:citation https://app.dimensions.ai/details/publication/pub.1080506739
18 https://app.dimensions.ai/details/publication/pub.1082450123
19 https://doi.org/10.1016/0002-8703(95)90368-2
20 https://doi.org/10.1016/0002-9394(86)90939-6
21 https://doi.org/10.1016/0037-7856(74)90039-0
22 https://doi.org/10.1016/0271-5384(81)90063-6
23 https://doi.org/10.1016/s0002-9394(14)74225-4
24 https://doi.org/10.1016/s0140-6736(75)92192-3
25 https://doi.org/10.1056/nejm197308022890506
26 https://doi.org/10.1097/00005650-196901000-00006
27 https://doi.org/10.1111/j.1755-3768.1992.tb04128.x
28 https://doi.org/10.1136/bjo.61.8.531
29 https://doi.org/10.1136/bjo.66.7.464
30 https://doi.org/10.1136/bjo.67.1.46
31 https://doi.org/10.1136/bmj.1.5638.218
32 https://doi.org/10.1136/bmj.2.6197.1031
33 https://doi.org/10.2105/ajph.83.5.711
34 schema:datePublished 1998-03
35 schema:datePublishedReg 1998-03-01
36 schema:description PURPOSE: To assess levels of compliance in elderly patients on timolol eyedrops for glaucoma. METHODS: A postal questionnaire was sent from the general practitioner to 86 patients over 55 years of age on repeat prescriptions for timolol eyedrops. The questionnaire asked details about the duration of treatment, family history, the level of understanding of the disease and the importance of treatment, other regular medication, side-effects attributed to the drops and how often patients omitted their drops. A search of practice and local hospital dispensing data was carried out to assess how frequently monthly repeat prescriptions for timolol eyedrops were dispensed over a 12 month period. This allowed a total volume to be calculated for each patient. RESULTS: Twenty-four per cent of patients admitted to omitting eyedrops either occasionally or frequently. Fifty-one per cent were found to have had insufficient drops dispensed to comply with treatment as prescribed. In non-complaint patients the mean period without drops was 85 days of the year, with a maximum of 165 days. CONCLUSION: Compliance with treatment is poor and patients underestimate their level of defaulting when questioned.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N6a778bd96cc148e1a1d629d02a974d50
41 Ndc4effb9f6194f048ed3a2f385c7b126
42 sg:journal.1097007
43 schema:name Compliance with timolol treatment in glaucoma
44 schema:pagination eye199856
45 schema:productId N41b9450ba18143f89f50fcfe3a27c8dc
46 N574cdbd636be4d60968314ec7aac2dcf
47 N7ac2b3a944df492e82a4c2737788dd6e
48 Nd5e6e7396dc242b6a51f483605994fe0
49 Ne654e50c6e0e4e9e84ec0233387c8412
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024045351
51 https://doi.org/10.1038/eye.1998.56
52 schema:sdDatePublished 2019-04-11T11:56
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Na575d97bf2a54eedbdffdc39f00a118d
55 schema:url http://www.nature.com/articles/eye199856
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N0a8bc173bb004610b9c7928bea93f4bc schema:affiliation https://www.grid.ac/institutes/grid.414191.8
60 schema:familyName Murphy
61 schema:givenName K M
62 rdf:type schema:Person
63 N31c79057b7f0463f9863dd245080d50b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Ophthalmic Solutions
65 rdf:type schema:DefinedTerm
66 N34b83284033b4a659278af8815306b21 rdf:first N0a8bc173bb004610b9c7928bea93f4bc
67 rdf:rest rdf:nil
68 N39d59dce1b0a4ea5b749ccd5335a2ee0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Female
70 rdf:type schema:DefinedTerm
71 N41b9450ba18143f89f50fcfe3a27c8dc schema:name dimensions_id
72 schema:value pub.1024045351
73 rdf:type schema:PropertyValue
74 N4ad39dae58e646828506bd199487195e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Family Practice
76 rdf:type schema:DefinedTerm
77 N5077a23d800b4ba087ae31c61be07868 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Antihypertensive Agents
79 rdf:type schema:DefinedTerm
80 N574cdbd636be4d60968314ec7aac2dcf schema:name doi
81 schema:value 10.1038/eye.1998.56
82 rdf:type schema:PropertyValue
83 N6a13041ac19947c08acf35ec4afc5272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name England
85 rdf:type schema:DefinedTerm
86 N6a778bd96cc148e1a1d629d02a974d50 schema:volumeNumber 12
87 rdf:type schema:PublicationVolume
88 N7ac2b3a944df492e82a4c2737788dd6e schema:name pubmed_id
89 schema:value 9683946
90 rdf:type schema:PropertyValue
91 N7c053ab6565e46e98d965aff67df398e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Glaucoma
93 rdf:type schema:DefinedTerm
94 N7c8dedd3ef3f43c6bad2fafda1a3e738 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Humans
96 rdf:type schema:DefinedTerm
97 N8870332cc4e64383ade480c42fe5317a rdf:first sg:person.01171364314.94
98 rdf:rest N34b83284033b4a659278af8815306b21
99 Na575d97bf2a54eedbdffdc39f00a118d schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 Na67d9845956343f3b8499d77c853b6ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Timolol
103 rdf:type schema:DefinedTerm
104 Nab873c953879472e92d36e41615a83ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Aged
106 rdf:type schema:DefinedTerm
107 Nbeceee15f5ee47059057dff2d5c8d0b4 schema:name The Surgery, School Lane, Alconbury, Huntingdon, Cambs PE17 5EQ, UK
108 rdf:type schema:Organization
109 Ncec0bedaf7334dc2b608b95e9d6038b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Patient Compliance
111 rdf:type schema:DefinedTerm
112 Nd2f8e82593e44154ae9397c62f4517d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Drug Administration Schedule
114 rdf:type schema:DefinedTerm
115 Nd5e6e7396dc242b6a51f483605994fe0 schema:name nlm_unique_id
116 schema:value 8703986
117 rdf:type schema:PropertyValue
118 Nd9a2397c4784435f816fba057952861f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 Ndc4effb9f6194f048ed3a2f385c7b126 schema:issueNumber 2
122 rdf:type schema:PublicationIssue
123 Ne5ea788cb1114275bdbc580b9f437f0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Middle Aged
125 rdf:type schema:DefinedTerm
126 Ne654e50c6e0e4e9e84ec0233387c8412 schema:name readcube_id
127 schema:value 728e7a1bcea73101eec0601d42258dfdbe9c7732bc720474603e5c9d689335a2
128 rdf:type schema:PropertyValue
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
133 schema:name Clinical Sciences
134 rdf:type schema:DefinedTerm
135 sg:journal.1097007 schema:issn 0950-222X
136 1476-5454
137 schema:name Eye
138 rdf:type schema:Periodical
139 sg:person.01171364314.94 schema:affiliation Nbeceee15f5ee47059057dff2d5c8d0b4
140 schema:familyName Rotchford
141 schema:givenName Alan P
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171364314.94
143 rdf:type schema:Person
144 https://app.dimensions.ai/details/publication/pub.1080506739 schema:CreativeWork
145 https://app.dimensions.ai/details/publication/pub.1082450123 schema:CreativeWork
146 https://doi.org/10.1016/0002-8703(95)90368-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040409546
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/0002-9394(86)90939-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001072527
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/0037-7856(74)90039-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040356753
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/0271-5384(81)90063-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044427350
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/s0002-9394(14)74225-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025525373
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/s0140-6736(75)92192-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006965428
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1056/nejm197308022890506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034091065
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1097/00005650-196901000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000806404
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1111/j.1755-3768.1992.tb04128.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051224189
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1136/bjo.61.8.531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046737054
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1136/bjo.66.7.464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044173821
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1136/bjo.67.1.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052616245
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1136/bmj.1.5638.218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034406825
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1136/bmj.2.6197.1031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029679341
173 rdf:type schema:CreativeWork
174 https://doi.org/10.2105/ajph.83.5.711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068874631
175 rdf:type schema:CreativeWork
176 https://www.grid.ac/institutes/grid.414191.8 schema:alternateName Hlabisa Hospital
177 schema:name Hlabisa Hospital, Private Bag X5001 Hlabisa KwaZulu-Natal, South Africa
178 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...